ACVR1 and diffuse intrinsic pontine glioma: ACVR1-targeting drugs, including LDN-214,117, LDN-193,189, and LDN212854, have shown potential in preclinical studies for treating this specific subtype of DIPG (Carvalho et al. 2019; Hoeman et al. 2019).